Rosuvastatin Calcium Tablets have no significant effect on uric acid. Rosuvastatin Calcium Tablet is a lipid-regulating drug, mainly used for primary hypercholesterolemia or mixed dyslipidemia in which dyslipidemia cannot be adequately controlled by dietary and other non-pharmacological treatments. It is also indicated for patients with pure familial hypercholesterolemia. Rosuvastatin Calcium Tablets have not been found to affect uric acid levels. Common adverse reactions after taking Rosuvastatin Calcium Tablets include nausea and vomiting, constipation, dizziness and headache, and myalgia. Proteinuria, elevated aminotransferases, myopathy, and rhabdomyolysis may occur in a very small number of people, but are usually mild and temporary. This drug is contraindicated in patients who are allergic to the product, during pregnancy and lactation, and in women who are at risk of pregnancy and are not using adequate contraception. Rosuvastatin Calcium Tablets are contraindicated in individuals with active liver disease, persistent elevation of serum aminotransferases and more than three times the upper limit of normal values, severe renal impairment, myopathy, and concomitant use of cyclosporine. Pay attention to monitoring the occurrence of adverse reactions during the use of the drug, monitoring liver function, renal function, creatine kinase, etc. If abnormalities in liver and kidney function, muscle pain, weakness or cramps, timely treatment. Rosuvastatin Calcium Tablets need to be used under the guidance of a professional doctor, and any discomfort in the process of taking it is recommended to consult a doctor immediately.